Tolerability and Plasma Drug Level Monitoring of Prolonged Subcutaneous Teicoplanin Treatment for Bone and Joint Infections

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00351-16
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Safety and Efficacy of Prolonged Use of Dalbavancin in Bone and Joint Infections

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Treatment of Bone, Joint, and Soft-Tissue Infections With Oral Ciprofloxacin.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1987English

A Gastric Resident Drug Delivery System for Prolonged Gram-Level Dosing of Tuberculosis Treatment

Science Translational Medicine
Medicine
2019English

Efficacy and Safety of Linezolid Versus Teicoplanin for the Treatment of MRSA Infections: A Meta-Analysis

Journal of Infection in Developing Countries
MedicineVirologyParasitologyInfectious DiseasesMicrobiology
2018English

Efficacy of Cotrimoxazole (Sulfamethoxazole-Trimethoprim) as a Salvage Therapy for the Treatment of Bone and Joint Infections (BJIs)

PLoS ONE
Multidisciplinary
2019English

Teicoplanin-Containing Cement Spacers for Treatment of Experimental Staphylococcus Aureus Joint Prosthesis Infection

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2003English

Surgical Treatment of Bone and Joint Tuberculosis

Southern Medical Journal
Medicine
1960English

Tolerability of Foscarnet as a Continuous Infusion for Treatment of Herpesvirus Infections

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Efficacy, Tolerability and Persistence of Subcutaneous Immunoglobulin Provided Through Immunology Physician Practices for the Treatment of Primary Immunodeficiencies

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy